Vicarious Surgical (RBOT) Stock Analysis & Winston Score
Vicarious Surgical is a medical robotics company that is developing a miniaturized surgical robot designed to perform minimally invasive abdominal surgeries. The system uses tiny cameras and robotic arms that can be inserted through a single small incision, giving surgeons a virtual reality-like view inside the patient's body. The company's target customers are hospitals and surgeons performing soft-tissue procedures. The company earns no meaningful revenue yet and is in the pre-commercial development stage, which explains its deeply negative margins and return on capital. Vicarious Surgical is based in the United States and has a very small market capitalization, competing in a space dominated by Intuitive Surgical, which makes the widely used da Vinci robot. The key risk is that the company must successfully complete regulatory clearance from the FDA and prove its system is safe and effective before it can generate sales — a process that requires significant ongoing cash burn with no guarantee of success.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Weak (0/30)
- Growth: Mixed (9/20)
- Cash Flow: Data not available (0/10)
- Stability: Weak (2/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.07
Market Cap: $0M
Sector: Healthcare
Industry: Medical - Devices
Exchange: Other OTC

